Carpal tunnel syndrome. Carpal tunnel syndrome, unspecified upper limb
Conditions
Interventions
Intervention 1: The first intervention group: patients who, in addition to receiving standard treatment, receive daily dose of vitamin B1 300 mg tablets (Kharazmi company) for one month. Interventio
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Occurrence of carpal tunnel syndrome diagnosed by a neurologist Patients aged 18 years and older Having a residual latency of more than 3 in the muscle nerve strip Falen's sign or positive Tinel's test or positive Pressure test
Exclusion criteria
Exclusion criteria: Dissatisfaction of patients History of allergy to group B supplements or krocina History of liver failure Using other medicinal supplements with antioxidant properties (vitamin E and C) in the last three months Using B6, B12 and B1 supplements before the study Suffering from diabetes or other neuropathic diseases as diagnosed by a neurologist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS pain measurement due to carpal tunnel syndrome. Timepoint: Before starting the study and then one month later. Method of measurement: VSA test questionnaire.;Residual latency in the Electromyography-Nerve Conduction Velocity. Timepoint: Before starting the study and then one month later. Method of measurement: Electromyography-Nerve Conduction Velocity test.;Symptom severity and functional status. Timepoint: Before starting the study and then one month later. Method of measurement: Boston Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactForouzan Ahmadpour
Khoram-Abad University of Medical Sciences
Outcome results
None listed